Evidence map›Paper›PMID 40946805›Full record

Trial reportThe American journal of clinical nutrition2025

Magnesium treatment increases gut microbiome synthesizing vitamin D and inhibiting colorectal cancer: results from a double-blind precision-based randomized placebo-controlled trial.

Elizabeth Sun, Xiangzhu Zhu, Reid M Ness, Harvey J Murff, Shan Sun, Chang Yu, Lei Fan, M Andrea Azcarate-Peril, Martha J Shrubsole, Qi Dai

3 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01105169 nacompletednot on this map

Personalized Prevention of Colorectal Cancer Trial (PPCCT)

TypeinterventionalSponsorVanderbilt University Medical CenterRan2011 to 2025Enrolled250ConditionsColorectal CancerArmsMagnesium glycinate, Placebo
NCT03265483 nacompletednot on this map

Effect of Magnesium Treatment on Vitamin D Resistance

TypeinterventionalSponsorVanderbilt University Medical CenterRan2014 to 2016Enrolled180ConditionsColorectal CancerArmsMagnesium glycinate, Placebo
NCT04229992 nacompletednot on this map

Calcium: Magnesium Balance, Microbiota, and Necroptosis and Inflammation

TypeinterventionalSponsorVanderbilt University Medical CenterRan2017 to 2024Enrolled250ConditionsColorectal CancerArmsMagnesium glycinate, Placebo
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elizabeth SunVanderbilt University School of Medicine, Nashville, TN, United States.
Xiangzhu ZhuDepartment of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States.
Reid M NessDivision of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Harvey J MurffDivision of Geriatric Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Shan SunDepartment of Bioinformatics and Genomics, University of North Carolina at Charlotte, Charlotte, NC, United States.
Chang YuDivision of Biostatistics, Department of Population Health, NYU Grossman School of Medicine, New York, NY, United States.
Lei FanDepartment of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States.
M Andrea Azcarate-PerilDivision of Gastroenterology and Hepatology, Department of Medicine, UNC School of Medicine, Chapel Hill, NC, United States.
Martha J ShrubsoleDepartment of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States.
Qi DaiDepartment of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States. Electronic address: qi.dai@vanderbilt.edu.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Calcium: magnesium balance, microbiota, and necroptosis and inflammationR01DK110166 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DAI, QI, SHRUBSOLE, MARTHA J. · 2017 to 2021
$3.4M
Personalized Prevention of Colorectal CancerR01CA149633 · NCI · VANDERBILT UNIVERSITY · PI DAI, QI, YU, CHANG · 2010 to 2014
$2.0M
Effect of magnesium treatment on vitamin D resistanceR03CA189455 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHRUBSOLE, MARTHA J. · 2014 to 2015
$167k
NCATS NIH HHS UL1 TR000445NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA149633NCI NIH HHS R03 CA189455NCRR NIH HHS UL1 RR024975NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK110166
6 · The paper itself

Abstract

backgroundCarnobacterium maltaromaticum and Faecalibacterium prausnitzii induce de novo gut synthesis of vitamin D to inhibit colorectal carcinogenesis in mice. Magnesium (Mg) treatment increases circulating vitamin D, and Mg homeostasis is dependent on TRPM7 genotype.

objectivesWe hypothesize that Mg treatment increases gut C. maltaromaticum and F. prausnitzii, and the effect differs by TRPM7 polymorphism.

methodsThe Personalized Prevention of Colorectal Cancer Trial is a double-blind, precision-based randomized controlled trial with 240 participants randomly assigned to both treatment and TRPM7 genotype. Stool, rectal swabs, and rectal mucosa were collected.

resultsOf 239 participants who completed the trial, 226 with valid microbiome data were analyzed (treatment n = 112, placebo n = 114). The interaction between treatment and TRPM7 genotype was only significant for C. maltaromaticum (P = 0.001) and F. prausnitzii (P = 0.02) in rectal swabs. In a stratified analysis by TRPM7 genotype without the missense variant, Mg treatment compared with placebo significantly increased abundance of C. maltaromaticum (0.217 ± 0.615 (23.01%) compared with -0.065 ± 0.588 (-6.30%); P = 0.006) and F. prausnitzii (0.105 ± 0.817 (2.13%) compared with -0.095 ± 0.856 (-1.92%); P = 0.04) in rectal swabs. The effect on C. maltaromaticum remained after multiple comparisons (Q = 0.05 for C. maltaromaticum across all sample types and genotypes). In those with the TRPM7 missense variant, Mg decreased C. maltaromaticum, but not F. prausnitzii, compared with placebo in rectal swabs [-0.065 ± 0.511 (-6.54%) compared with 0.133 ± 0.503 (13.30%); adjusted P = 0.04]. The effect did not remain after false discovery rate correction. Mg treatment's effect on C. maltaromaticum in rectal swabs primarily appeared in females, and the treatment-genotype interaction remained significant.

conclusionsIn individuals with adequate TRPM7 function, Mg supplementation increases the abundance of C. maltaromaticum and F. prausnitzii. CLINICAL TRIAL REGISTRY: This trial was registered at clinicaltrials.gov as NCT04229992 (https://clinicaltrials.gov/study/NCT04229992?term=NCT04229992&rank=1). The parent study is registered as NCT03265483, and another relevant study is registered as NCT01105169.

Indexed as

Colorectal NeoplasmsGastrointestinal MicrobiomeMagnesiumVitamin DAgedDouble-Blind MethodFecesFemaleGenotypeHumansMaleMiddle AgedProtein Serine-Threonine KinasesRectumTRPM Cation ChannelsMagnesiumProtein Serine-Threonine KinasesTRPM7 protein, humanTRPM Cation ChannelsVitamin Dcolorectal cancermagnesium treatmentmicrobiomeprecision medicinerandomized controlled trial

Identifiers

PMID40946805
PMCPMC12799435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.